Literature DB >> 7043174

Free and total insulin integrated concentrations in insulin dependent diabetes.

J T Hayford, R G Thompson.   

Abstract

Studies of the 24 hr insulin concentration profiles in diabetic subjects on chronic exogenous insulin have been hampered by the presence of endogenous anti-insulin antibody, which gives spurious estimates of radioimmunoassayable insulin concentrations. The introduction of polyethylene glycol precipitation of endogenous antibody has allowed development of reliable assays for determination of free and total insulin concentration in subjects on insulin therapy. This article reports our observations of plasma free and total insulin concentration in 50 Type I and Type II ambulatory insulin dependent diabetics, utilizing a continuous 24 hr blood withdrawal technique. In response to exogenous insulin, study subjects had marked elevations in insulin concentrations compared to controls. Mean free insulin integrated concentration was 3.5-fold higher in diabetics than nondiabetics. Mean total insulin integrated concentration was 868 microunits/ml, more than 20 times in excess of total insulin concentration in nondiabetics. There was a wide range among diabetics in the percentage of total insulin in the free insulin fraction. Neither free nor total insulin integrated concentration correlated with dose of exogenous insulin. Free and total insulin concentration profiles showed a limited range of variation in insulin concentration during the 24 hr of study, no subject having a profile that mimicked that observed in nondiabetic subjects. Glucose integrated concentration showed no correlation with free insulin integrated concentration, however, it did correlate inversely with the percentage of total insulin in the free insulin fraction. These data emphasize the difficulty in establishing normal patterns of insulin among diabetic subjects on conventional subcutaneous insulin therapy.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7043174     DOI: 10.1016/0026-0495(82)90116-0

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  6 in total

1.  Free insulin concentrations in immediately extracted plasma samples and their relationships to clinical and metabolic parameters in insulin-treated diabetic patients.

Authors:  R Giannarelli; P Marchetti; M Giannecchini; G Di Cianni; P Cecchetti; A Masoni; R Navalesi
Journal:  Acta Diabetol Lat       Date:  1988 Jul-Sep

Review 2.  Tissue barriers and novel approaches to achieve hepatoselectivity of subcutaneously-injected insulin therapeutics.

Authors:  Juntang Shao; Jennica L Zaro; Wei-Chiang Shen
Journal:  Tissue Barriers       Date:  2016-03-04

3.  Pseudomonas aeruginosa biofilms perturb wound resolution and antibiotic tolerance in diabetic mice.

Authors:  Chase Watters; Katrina DeLeon; Urvish Trivedi; John A Griswold; Mark Lyte; Ken J Hampel; Matthew J Wargo; Kendra P Rumbaugh
Journal:  Med Microbiol Immunol       Date:  2012-09-25       Impact factor: 3.402

4.  The source of the circulating aggregate of insulin in type I diabetic patients is therapeutic insulin.

Authors:  M Maislos; P M Mead; D H Gaynor; D C Robbins
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

5.  Aorta and muscle metabolism in pigs with peripheral hyperinsulinaemia.

Authors:  K Falholt; K G Alberti; L G Heding
Journal:  Diabetologia       Date:  1985-01       Impact factor: 10.122

6.  The course and determinants of insulin action in type 1 (insulin-dependent) diabetes mellitus.

Authors:  H G Nijs; J K Radder; M Frölich; H M Krans
Journal:  Diabetologia       Date:  1989-01       Impact factor: 10.122

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.